Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Brixton Biosciences in the transaction. Brixton Biosciences, a clinical stage life sciences company, announced it has raised $33...
Brixton Biosciences’ $33 Million Series B Financing Round
Cultivo’s $14 Million Series A Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented MassMutual Ventures in the transaction. Cultivo announced it raised $14 million in Series A financing, to accelerate its mission...
Prove Identity’s $40 Million Funding Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented MassMutual Ventures in the transaction. Prove Identity announced $40 million funding round led by MassMutual Ventures and Capital One Ventures. The...
Osmoses’ $11 Million Series Seed Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Osmoses in the transaction. Osmoses announced its $11 million Series Seed financing led by Energy Capital Ventures, and included...
Flywire’s $256 Million Common Stock Offering
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian acted as counsel to Flywire, and Goodwin Procter acted as counsel to the underwriters. Flywire Corporation (Nasdaq: FLYW) announced its underwritten...
AltC Acquisition Corp.’s Business Combination with Oklo
Weil, Gotshal & Manges LLP represented AltC Acquisition Corp., while Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP represented Oklo Inc. in the transaction. An advanced...
Toku’s $7 Million Seed Series Investment Round
CMS Carey & Allende and Wilmer Cutler Pickering Hale and Dorr advised Toku, while Carey & Co. and Gunderson Dettmer advised F-Prime on the transaction. Toku closed...
Flywire’s IPO
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP advised Flywire on the deal. Boston-based global payments enablement and software company, Flywire, announced its initial public offering. The company...